silybin has been researched along with Lung Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Duan, W; Feng, Y; Jin, Z; Li, Y; Liang, Z; Wang, H; Yan, J; Yan, X; Yang, J; Yang, Y; Yi, W; Yu, S | 1 |
1 other study(ies) available for silybin and Lung Adenocarcinoma
Article | Year |
---|---|
Inhibition of SIRT1 signaling sensitizes the antitumor activity of silybin against human lung adenocarcinoma cells in vitro and in vivo.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antioxidants; Apoptosis; Caspase 3; Cell Adhesion; Cell Movement; Cell Proliferation; Cell Survival; Glutathione; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred NOD; Mice, Nude; Mice, SCID; Random Allocation; Reactive Oxygen Species; RNA, Small Interfering; Silybin; Silymarin; Sirtuin 1; Transfection; Xenograft Model Antitumor Assays | 2014 |